NEW YORK (TheStreet) -- With stocks challenging 52-week highs, multi-year year highs and in some cases all-time highs, it's surprising to observe that the performances of many stocks after reporting better than expected earnings have been lackluster at best.Today I update my profiles for 11 stocks that reported quarterly results between Jan. 30 and Feb. 13. Eight reported better than expected EPS, while three missed. On Jan. 29 I wrote,
Reading the TableOV/UN Valued: Stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine. VE Rating: A "1-engine" rating is a strong sell, a "2-engine" rating is a sell, a "3-engine" rating is a hold, a "4-engine" rating is a buy and a "5-engine" rating is a strong buy. Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage. Forecast 1-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the table are projected to move higher by that percentage over the next 12 months. Trailing 12 months price-to-earnings ratio
Here are my updated buy-and-trade parameters and earnings scorecard: Boeing ( BA - Get Report) ($74.78) beat earnings estimates by 9 cents a share reporting an EPS of $1.28 on Jan. 30. Given the clouds of the Dreamliner the stock stayed range bound, while maintaining a buy rating. The weekly chart shifts to negative with a weekly close below the five-week modified moving average at $75.12. My semiannual value level lags at $59.67 with my monthly risky level at $76.40.
United Parcel Service ( UPS - Get Report) ($82.50) missed EPS estimates by 6 cents earning $1.32 per share on Jan. 31, but the stock proved to be resilient. The stock traded down to $79.00 on Feb. 1 then up to a new multi-year high at $83.08 on Feb. 12. UPS kept a buy rating during this volatility with an overbought weekly chart profile and the five-week MMA at $79.37. Stability was influenced by my semiannual pivot at $80.21 with a monthly value level at $75.82 and weekly risky level at $84.84. Chevron ( CVX - Get Report) ($115.53) missed EPS estimates by 5 cents earning $2.98 per share on Feb. 1. The stock drifted sideways since then while maintaining a buy rating with a positive weekly chart profile, and the five-week MMA at $113.59. My semiannual value level is $111.22 with a weekly pivot at $118.32, a quarterly risky level at $120.94 and annual risky levels at $122.26 and $123.08. Merck ( MRK - Get Report) ($41.15) beat EPS estimates by 2 cents earning 83 cents per share on Feb. 1. Guidance was light and the stock declined from $43.25 on Jan. 31 to $40.83 on Feb. 4 then sideways since then. The stock has maintained a buy rating with a negative weekly chart profile and the five-week MMA at $42.23. My quarterly value level is $40.81 with my semiannual risky level at $43.41.